zw171
zw171: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zymeworks Inc. (ZYME) | Phase 1 |
Clinical Trials (1)
A Phase 1, Open-label, Multicenter Study of ZW171 in Participants With Advanced or Metastatic Ovarian Cancer, Non-small Cell Lung Cancer (NSCLC), and Other Mesothelin Expressing Cancers
Frequently asked questions
Who is developing zw171?
zw171 is being developed by Zymeworks Inc..
How many clinical trials involve zw171?
BioSniper tracks 1 clinical trial involving zw171.
Get deeper analysis on zw171
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis